Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade

Guo, Penga; Nishiyama, Akirab; Rahman, Matlubura,b; Nagai, Yukikoc; Noma, Takahisaa; Namba, Tsunetatsua; Ishizawa, Makotoa; Murakami, Kazushid; Miyatake, Akirac; Kimura, Shojib; Mizushige, Katsufumid; Abe, Youichib; Ohmori, Kojia; Kohno, Masakazua

doi: 10.1097/01.hjh.0000226200.73065.5d
Original papers: Inflammation and oxidative stress

Objective We investigated the contribution of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase-dependent reactive oxygen species (ROS) generation to the pathogenesis of diastolic heart failure (DHF) in Dahl salt-sensitive (DS) hypertensive rats, with the aim of testing our hypothesis that the cardioprotective effects of angiotensin II (Ang II) blockade are provided by the suppression of this pathway.

Methods DS rats were maintained on high (H: 8.0% NaCl) or low (L: 0.3% NaCl) salt diets from age 7 to 17 weeks. DS/H rats were also treated with candesartan cilexetil (10 mg/kg per day, orally) or a superoxide dismutase mimetic, tempol (3 mmol/l in drinking water) from age 7 to 17 weeks.

Results DS/H rats represented hypertension, left ventricular (LV) relaxation abnormality and myocardial stiffening with preserved systolic heart function. As compared with DS/L rats, DS/H rats showed higher levels of transforming growth factor-β (TGF-β), connective tissue growth factor (CTGF), p22phox and gp91phox mRNA expression, NADPH oxidase activity and thiobarbituric acid-reactive substance (TBARS) contents in LV tissues. Gene expression of uncoupling protein-2 (UCP-2), an inner mitochondrial membrane proton transporter, was also 2.8 ± 0.5-fold higher. In DS/H rats, treatment with candesartan did not alter blood pressure, but resulted in a marked improvement of the hemodynamic deterioration; these therapeutic effects were accompanied by decreases in myocardial NADPH oxidase activity, TBARS contents and the expression of TGF-β, CTGF, p22phox, gp91phox and UCP-2. Similar therapeutic effects were provided by treatment with tempol in DS/H rats.

Conclusions Our data suggest that NADPH oxidase-mediated ROS production contributes to the pathogenesis of DHF in DS hypertensive rats, and that the cardioprotective effects of AngII blockade are, at least partially, mediated through the suppression of this pathway.

aDepartment of Cardiorenal and Cerebrovascular Medicine, Japan

bDepartment of Pharmacology, Japan

cLife Science Research Center, Kagawa University Medical School, Kagawa

dCardiovascular Division, Takamatsuhigashi Hospital, Kagawa, Japan

Received 11 March, 2005

Accepted 20 February, 2006

Correspondence and requests for reprints to Akira Nishiyama MD, PhD, Department of Pharmacology, Kagawa University Medical School, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan Tel: +81 (87) 898 5111 (Ext. 2502); fax: +81 (87) 891 2126; e-mail:

Sponsorship: This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (17790171), a Salt Sciences Research Grant (05C2), and a grant from the Japan Research Foundation for Clinical Pharmacology (to A.N.). Candesartan cilexetil was supplied by Takeda Pharmaceutical Industries, Ltd (Osaka, Japan).

© 2006 Lippincott Williams & Wilkins, Inc.